New drug trial aims to tame severe eczema itch and rash

NCT ID NCT07230860

Recruiting now Disease control Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

Summary

This study is testing an investigational drug called JNJ-95597528 to see if it can reduce the skin rash and severe itching of moderate-to-severe eczema (atopic dermatitis). About 180 adult participants will receive either the drug or a placebo for 12 weeks to compare effectiveness and safety. The main goal is to see how many people achieve a 75% improvement in their eczema severity score.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Arlington Dermatology
RECRUITING

Rolling Meadows, Illinois, 60008, United States
CCA Medical Research Corporation
RECRUITING

Ajax, Ontario, L1S7K8, Canada
Center for Clinical Studies
RECRUITING

Houston, Texas, 77004, United States
Chang Gung Memorial Hospital
RECRUITING

Kaohsiung City, 833, Taiwan
China Japan Friendship Hospital
RECRUITING

Beijing, 100029, China
Chung Shan Medical University Hospital
RECRUITING

Taichung, 40201, Taiwan
Clinical Research Philadelphia
RECRUITING

Philadelphia, Pennsylvania, 19114, United States
Dawes Fretzin Clinical Research Group
RECRUITING

Indianapolis, Indiana, 46250, United States
DermEdge Research
RECRUITING

Mississauga, Ontario, L4Y 4C5, Canada
Driven Research LLC
RECRUITING

Coral Gables, Florida, 33134, United States
First OC Dermatology
RECRUITING

Fountain Valley, California, 92708, United States
Hosp. of Chengde Medical University
RECRUITING

Chengde, 067030, China
Jitaikai Tachikawa dermatology clinic
RECRUITING

Tachikawa, 190 0023, Japan
Kaohsiung Veterans General Hospital
RECRUITING

Kaohsiung City, 813, Taiwan
Kindai University Hospital
RECRUITING

Sakai, 590 0197, Japan
Kume Clinic
RECRUITING

Nishiku, 593-8324, Japan
Linkou Chang Gung Memorial Hospital
RECRUITING

Taoyuan District, 333, Taiwan
Miyata Dermatology Clinic
RECRUITING

Matsudo, 271-0092, Japan
National Taiwan University Hospital
RECRUITING

Taipei, 10048, Taiwan
Nomura Dermatology Clinic
RECRUITING

Yokohama, 221 0825, Japan
Oregon Dermatology and Research Center
RECRUITING

Portland, Oregon, 97210, United States
Progressive Clinical Research
RECRUITING

San Antonio, Texas, 78213, United States
Red River Research Partners LLC
RECRUITING

Fargo, North Dakota, 58103, United States
Sanmenxia Central Hospital
RECRUITING

Sanmenxia, 472000, China
SimcoDerm Medical and Surgical Dermatology Centre
RECRUITING

Barrie, Ontario, L4M 7G1, Canada
Southern California Dermatology
RECRUITING

Santa Ana, California, 92701, United States
Taipei Medical University Shuang Ho Hospital
RECRUITING

New Taipei City, 235, Taiwan
Tri-Service Genaral Hospital
RECRUITING

Taipei, 114202, Taiwan
Wuxi People s Hospital
RECRUITING

Wuxi, 214100, China
XLR8 Medical Research
RECRUITING

Windsor, Ontario, N8T 1E6, Canada

Conditions

Explore the condition pages connected to this study.

DERMATITIS ATOPIC